Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
PharmaCyte Biotech, Inc. (NVLX)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
11/19/2021
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/23/2021
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/10/2021
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/02/2021
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/22/2018
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/28/2017
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/02/2014
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
11/12/2014
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
10/29/2014
424B2
Form 424B2 - Prospectus [Rule 424(b)(2)]
11/03/2004
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy